re: thoughts on shaw report I have just seen the report and think it's very conservative.
Keep in mind:
1. They estimate 5% royalty, when I would expect 10%
2. Their 2005 estimates only include 2m Hep C kits (ie 1st year in ramp up mode). But full operational mode may indicate many times that. With 170m chronic sufferers and 3-4m new cases per year, I would expect that figure to be at least 10m kits per year rather than 2m.
If you take the above into account, the revenue would move from US$6.5m (as per Shaw report) to US$48.6m, again, assuming:
- 10% royalty
- full operation with Hep C
Given very low overheads on this revenue, this is huge!
Have I missed the plot with these numbers?
- Forums
- ASX - By Stock
- SLT
- gmt what are your thoughts on report?
gmt what are your thoughts on report?, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online